I help pharmaceutical and AI companies figure out the how of AI and research informatics — from strategy and architecture to the messy reality of delivery. Whatever your size, startup to enterprise.
What sets me apart from most consultants in this space is simple: I've done the work myself.
Over 24 years at Novo Nordisk I built and led the teams, platforms and strategies that took digital transformation in research from concept to reality — rolling out a generative-AI solution to hundreds of users in under a year, and modernising digital biology platforms that cut target-validation time many times over.
I hold a PhD in structural chemistry and 25+ peer-reviewed publications — from experimental crystallography in the 1990s to DNA language models and AlphaFold-based drug discovery, in Nature Medicine, Nature Communications and Bioinformatics. Hands-on with ML, knowledge graphs and GenAI — the architecture decisions and the messy reality of making these work inside a regulated enterprise.
“Combining deep hands-on technical knowledge with strong strategic insight, he is a trusted advisor for the development, evaluation, and implementation of cutting-edge data and AI/ML platforms … equally comfortable working independently and delivering high-quality results end-to-end.”
“Dennis consistently demonstrated exceptional scientific rigor combined with a strong ability to translate complex data into actionable insights.”
“Dennis possesses an exceptional blend of deep expertise in life sciences and advanced computer skills, ranging from bioinformatics and text analytics to machine learning, knowledge graphs, and generative AI.”
“Dennis excels at combining deep business and technology expertise with exceptional drive, commitment, and enthusiasm … to deliver cutting-edge products.”
Current work spans strategic and hands-on engagements with pharmaceutical and AI companies.
Whether you need a sounding board, a delivery partner, or someone to lead the transformation from the inside.
I advise pharmaceutical and AI companies on digital strategy, AI adoption and research-informatics transformation — and I'm open to the right senior leadership role, permanent or fractional.